Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:36 PM
Study NCT ID:
NCT04550351
Status:
UNKNOWN
Last Update Posted:
2021-01-27
First Post:
2020-08-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)
Sponsor:
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-16
First Submit QC Date:
None
Study First Post Date:
2020-09-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-26
Last Update Post Date:
2021-01-27
Last Update Post Date Type:
ACTUAL